CoChat

Reducing the harm of opioid overdose with the safe use of naloxone: a pharmacologic review

Kim, Hong K, Nelson, Lewis S · 2015 · Expert Opinion on Drug Safety

The DOI matches its Crossref record; 97 of the 98 references it cites were found in a registry or an index.

Abstract

INTRODUCTION: Opioid overdose fatality has increased threefold since 1999. As a result, prescription drug overdose surpassed motor vehicle collision as the leading cause of unintentional injury-related death in the USA. Naloxone , an opioid antagonist that has been available for decades, can safely reverse opioid overdose if used promptly and correctly. However, clinicians often overestimate the dose of naloxone needed to achieve the desired clinical outcome, precipitating acute opioid withdrawal syndrome (OWS). AREAS COVERED: This article provides a comprehensive review of naloxone's pharmacologic properties and its clinical application to promote the safe use of naloxone in acute management of opioid intoxication and to mitigate the risk of precipitated OWS. Available clinical data on opioid-receptor kinetics that influence the reversal of opioid agonism by naloxone are discussed. Additionally, the legal and social barriers to take home naloxone programs are addressed. EXPERT OPINION: Naloxone is an intrinsically safe drug, and may be administered in large doses with minimal clinical effect in non-opioid-dependent patients. However, when administered to opioid-dependent patients, naloxone can result in acute opioid withdrawal. Therefore, it is prudent to use low-dose naloxone (0.04 mg) with appropriate titration to reverse ventilatory depression in this population.

Overview

Integrity signals

Registry

Crossref · 10.1517/14740338.2015.1037274

Cites

97 of 97 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 97 references

Research works printed but not linked: 15

  1. Paulozzi LJ, 2011, MMWR Surveill Summ, 60, 60
  2. Kochanek KD, 2011, Natl Vit Stat Rep, 59, 51
  3. Centers for Disease C, Prevention, 2012, MMWR. Morb Mortal Wkly Rep, 61, 493
  4. Nelson LS, 2015, Opioid Antagonists
  5. Kim S, 1997, J Nucl Med, 38, 1726
  6. 10.1097/00000542-200607000-00012 · DOI · Paper page
  7. Anderson JA, 1988, Anesth Prog, 35, 43
  8. Longnecker DE, 2012, Anesthesiology
  9. Stone CK, 2008, Current diagnosis & treatment emergency medicine
  10. Connors NC, 2014, J Med Tox, 10, 76
  11. Atchabahian A, 2013, The anesthesia guide
  12. 10.1001/jama.1995.03530070060031 · doi:10.1001/jama.1995.03530070060031
  13. Lewis JM, 1984, Am J Dis Child, 138, 944
  14. Straus MM, 2013, Subst Abuse Rehabil, 2013
  15. Centers for Disease Control and Prevention, 2012, MMWR Morb Mortal Wkly Rep, 61, 101

Cited by

See all 116

Metadata

Authors
Kim, H. K., & Nelson, L. S.
Affiliations
  • University of Maryland, Baltimore (US)
  • Bellevue Hospital Center (US)
Venue
Expert Opinion on Drug Safety
Published
2015-04-12
Volume
14
Issue
7
Pages
1137-1146
ISSN
  • 1474-0338 (ISSN-L)
  • 1744-764X
OpenAlex
W2126273530
Cited by
116
References
98
Citations by year
2026: 7 · 2025: 11 · 2024: 8 · 2023: 6 · 2022: 16 · 2021: 8 · 2020: 16 · 2019: 18 · 2018: 7 · 2017: 11 · 2016: 6 · 2015: 2
FWCI
1.25
Type
journal article
Language
en
Open access
closed
Locations
  • Expert Opinion on Drug Safety (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
Keywords
naloxone, opioid overdose, opioid antagonists, opioid toxicity, opioid overdose deaths, opioid use disorder
MeSH terms
Analgesics, Opioid, Humans, Naloxone, Narcotic Antagonists, Treatment Outcome, Drug Overdose

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Reducing the harm of opioid overdose with the safe use of naloxone: a pharmacologic review. https://app.cochat.ai/papers/10.1517/14740338.2015.1037274
The paper
Kim, H. K., & Nelson, L. S. (2015). Reducing the harm of opioid overdose with the safe use of naloxone: a pharmacologic review. Expert Opinion on Drug Safety. https://doi.org/10.1517/14740338.2015.1037274

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.